Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rufloxacin Hydrochloride Capsules

Approval Number

国药准字H20030022

Company武汉海特生物制药股份有限公司

Registration Date

July 13, 2020

Previous Approval Numbers

国药准字H20030022

Drug Information

Generic Name

盐酸芦氟沙星胶囊

Brand Name

欧力康

Dosage Form

胶囊剂

Strength

0.1g(按C₁₇H₁₈FN₃O₃S计)

Drug Type

化学药品

Registration Date

July 13, 2020

Company Information

Applicant Company

Company Name武汉海特生物制药股份有限公司

Company Address

武汉经济技术开发区海特科技园

Manufacturing Company

Company Name湖北四环制药有限公司

Company Address

湖北省武汉市经济技术开发区绿岛科技园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy